Evaluating a self-guided internet-based pain course for individuals with fibromyalgia and anxiety and/or depressio

Not Applicable

Completed

• Conditions: Fibromyalgia, Major Depressive Disorder, Generalized Anxiety Disorder, Panic Disorder, Social Phobia; Mental and Behavioural Disorders

• Registration Number: ISRCTN85116527
• Lead Sponsor: niversity of Regina (Canada)

Brief Summary

2017 results in https://pubmed.ncbi.nlm.nih.gov/27984490/ (added 10/05/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-04-15
• Study Completion: 2014-12-31
• Last Update Posted: 24 May 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1. Resident of Canada
2. Aged 18 years or older, either sex
3. Currently experiencing clinically significant symptoms of Fibromyalgia, depression, anxiety, social phobia, and/or panic
4. Has regular access to a computer, Internet, and printer
5. Comfortable using the Internet

Exclusion Criteria

1. Not a resident of Canada
2. Less than 18 years of age
3. Has no regular access to a computer, Internet, and use of printer
4. Currently receiving psychotherapeutic treatment for pain, anxiety, or depression elsewhere or in some other form
5. Started a new psychotropic medication within the past month or had a change in dosage within the past month
6. Self-reported current problems with alcohol use or substance use
7. Self-reported current problems with psychotic disorder or bipolar disorder, or severe symptoms of depression, including frequent suicidal ideation

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. Revised Fibromyalgia Impact Questionnaire<br> 2. Brief Pain Inventory<br> 3. Patient Health Questionnaire- 9 Item<br> 4. Generalized Anxiety Disorder ? 7 Item<br> These will be administered at baseline, weekly, post-treatment, 1- and 3-month follow-up.<br>

Secondary Outcome Measures

Name	Time	Method
<br> 1. Hopital Anxiety and Depression Scale measured at baseline, post-treatment and at 3-month follow up<br> 2. Pain Self-Efficacy Questionnaire measured at baseline, post-treatment and at 3-month follow up<br> 3. Pain Responses Self-Statements at baseline, post-treatment<br> 4. Visual Analogue Scale for Pain at baseline, weekly, post-treatment<br> 5. Fatigue Symptom Inventory at baseline, post-treatment<br> 6. TAMPA Scale of Kinesiophobia at baseline, post-treatment<br> 7. Medical Outcomes Study Short Form at baseline, post-treatment and at 3-month follow up<br> 8. Treatment Satisfaction Questionnaire measured post-treatment<br> 9. Client Feedback Open-Ended Questions measured post-treatment<br>